Introduction: This study aimed to examine the susceptibility profile of Escherichia coli in urinary tract infections (UTIs) among elderly diabetic patients to support judicious and evidence-based antibiotic use. Methods: From January 2021 to December 2022, urine culture results were analyzed to determine the distribution of pathogens, especially E. coli, and their drug susceptibility. Results:E. coli infection was the most prevalent infection in elderly diabetic patients with UTIs, accounting for 32.6% of cases. Moreover, this bacterium’s multiple resistance rate (38.3%) was significantly higher than other bacteria’s multiple resistance rate (χ2 = 81.644, p < 0.05). Compared to older diabetic patients with optimal glucose control (HbA1c ≤7.0%), patients with poor glycemic control (HbA1c >7.0%) had lower resistance rates to lactams, and urine pH values were higher (p < 0.05). Conclusion: The most common cause of UTIs is E. coli, with advanced age and diabetes being the main risk factors. To optimize UTI treatment safety and efficacy, antibiotics should be administered based on the patient’s age and blood glucose control.

Journal Section:
Research Article
Keywords:
Urinary tract infections, Diabetes, Antibiotic treatment, Age and blood glucose control
1.
Guay
DR
.
Cranberry and urinary tract infections
.
Drugs
.
2009
;
69
(
7
):
775
–
807
.
Google Scholar
PubMed
 
2.
Cooper
TE
,
Teng
C
,
Howell
M
,
Teixeira-Pinto
A
,
Jaure
A
,
Wong
G
.
D-mannose for preventing and treating urinary tract infections
.
Cochrane Database Syst Rev
.
2022
;
8
:
Cd013608
.
Google Scholar
PubMed
 
3.
Munoz
JA
,
Uhlemann
AC
,
Barasch
J
.
Innate bacteriostatic mechanisms defend the urinary tract
.
Annu Rev Physiol
.
2022
;
84
:
533
–
58
.
Google Scholar
PubMed
 
4.
Boon
HA
,
Van den Bruel
A
,
Verbakel
JY
.
GPs’ perspectives on diagnosing childhood urinary tract infections: a qualitative study
.
Br J Gen Pract
.
2022
;
72
(
723
):
e729
–
36
.
Google Scholar
PubMed
 
5.
Bruxvoort
KJ
,
Bider-Canfield
Z
,
Casey
JA
,
Qian
L
,
Pressman
A
,
Liang
AS
, et al.
Outpatient urinary tract infections in an era of virtual healthcare: trends from 2008 to 2017
.
Clin Infect Dis
.
2020
;
71
(
1
):
100
–
8
.
Google Scholar
PubMed
 
6.
Lee
DS
,
Choe
HS
,
Kim
HY
,
Yoo
JM
,
Bae
WJ
,
Cho
YH
, et al.
Role of age and sex in determining antibiotic resistance in febrile urinary tract infections
.
Int J Infect Dis
.
2016
;
51
:
89
–
96
.
Google Scholar
PubMed
 
7.
Venmans
LM
,
Sloof
M
,
Hak
E
,
Gorter
KJ
,
Rutten
GE
.
Prediction of complicated urinary tract infections in patients with type 2 diabetes: a questionnaire study in primary care
.
Eur J Epidemiol
.
2007
;
22
(
1
):
49
–
54
.
Google Scholar
PubMed
 
8.
Easter
SR
,
Cantonwine
DE
,
Zera
CA
,
Lim
KH
,
Parry
SI
,
McElrath
TF
.
Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia
.
Am J Obstet Gynecol
.
2016
;
214
(
3
):
387.e1
–
3877
.
Google Scholar
PubMed
 
9.
Foxman
B
.
Epidemiology of urinary tract infections: incidence, morbidity, and economic costs
.
Am J Med
.
2002
;
113
(
Suppl 1A
):
5S
–
13S
.
Google Scholar
PubMed
 
10.
Wiley
Z
,
Jacob
JT
,
Burd
EM
.
Targeting asymptomatic bacteriuria in antimicrobial stewardship: the role of the microbiology laboratory
.
J Clin Microbiol
.
2020
;
58
(
5
):
e00518–18
.
Google Scholar
PubMed
 
11.
Confederat
LG
,
Condurache
MI
,
Alexa
RE
,
Dragostin
OM
.
Particularities of urinary tract infections in diabetic patients: a concise review
.
Medicina
.
2023
;
59
(
10
):
1747
.
Google Scholar
Crossref
Search ADS
PubMed
 
12.
Pang
S
,
Li
S
,
Cheng
H
,
Luo
Z
,
Qi
X
,
Guan
F
, et al.
Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models
.
Front Mol Neurosci
.
2022
;
15
:
1025066
.
Google Scholar
Crossref
Search ADS
PubMed
 
13.
Medina
M
,
Castillo-Pino
E
.
An introduction to the epidemiology and burden of urinary tract infections
.
Ther Adv Urol
.
2019
;
11
:
1756287219832172
.
Google Scholar
Crossref
Search ADS
PubMed
 
14.
Abdul Raheem
R
,
Hussein
M
,
Al-Din
N
.
Causative organism of urinary tract infection and drug resistance in children at child’s Central Teaching Hospital in Baghdad City
.
J Pak Med Assoc
.
2019
;
69(Suppl 3)
(
8
):
S59
–
63
.
Google Scholar
PubMed
 
15.
Xie
X
,
Shrimpton
J
,
Doody
GM
,
Conaghan
PG
,
Ponchel
F
.
B-cell capacity for differentiation changes with age
.
Aging Cell
.
2021
;
20
(
4
):
e13341
.
Google Scholar
Crossref
Search ADS
PubMed
 
16.
Hamdan
H
,
Kubbara
E
,
Adam
A
,
Hassan
O
,
Suliman
S
,
Adam
I
.
Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan
.
Ann Clin Microbiol Antimicrob
.
2015
;
14
:
26
.
Google Scholar
Crossref
Search ADS
PubMed
 
17.
Raya
S
,
Belbase
A
,
Dhakal
L
,
Govinda Prajapati
K
,
Baidya
R
,
Kishor Bimali
N
.
In-vitro biofilm formation and antimicrobial resistance of Escherichia coli in diabetic and nondiabetic patients
.
Biomed Res Int
.
2019
;
2019
:
1474578
.
Google Scholar
Crossref
Search ADS
PubMed
 
18.
Hu
D
,
Zhao
Y
,
Wang
H
,
Min
H
,
Cui
Y
,
Luo
K
, et al.
Multiple draft tubes airlift loop membrane bioreactor as an efficient system for acidic 7-amino cephalosporanic acid (7-ACA) wastewater treatment
.
Bioresour Technol
.
2020
;
304
:
123014
.
Google Scholar
Crossref
Search ADS
PubMed
 
© 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.